Jamalul, Linda S.

HRN: 20-92-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
CEFTRIAXONE 1G (VIAL)
11/30/2024
12/07/2024
IV
2g
OD
Typhoid Fever
Waiting Final Action 
12/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/02/2024
12/09/2024
IVT
500mg
Q8
T/C Intestinal Amoebiasis
Waiting Final Action 
01/28/2025
METRONIDAZOLE 500MG (TAB)
01/28/2025
02/04/2025
PO
500mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: